The recent surge in bolt-on M&A in the life sciences sector is being fueled by the use of contingent value rights.
Read more here: Return of the CVR, Adam Golden, Mark Appleton (freshfields.us)
Return of the CVR
Jul 11, 2023
Posted by Freshfields
Jul 11, 2023
Posted by Freshfields
The recent surge in bolt-on M&A in the life sciences sector is being fueled by the use of contingent value rights.
Read more here: Return of the CVR, Adam Golden, Mark Appleton (freshfields.us)